Clinical Trial Update: A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial updating maintenance niraparib versus placebo in platinum-sensitive ovarian cancer has completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Platinum-sensitive Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Tesaro, Inc. | Conditions: Ovarian Neoplasms, Platinum Sensitive Ovarian Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-05-01